D-Wave Quantum Inc. (QBTS): Nasdaq/NYSE listing notice — D-Wave Quantum receives NYSE non-compliance notice for share price below $1.00

D-Wave Quantum Inc.

NYSE notified D-Wave on March 16, 2023 that average closing price was below $1.00 for 30 consecutive trading days.
Company has six months to cure; can regain compliance if closing price ≥$1.00 on last trading day of any month and 30-day average ≥$1.00.
Intends to consider alternatives including a reverse stock split subject to shareholder approval.
No immediate delisting; common stock continues trading on NYSE during the cure period.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

D-Wave Quantum Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

nge Act. ☐ Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On March 16, 2023 , D-Wave Quantum Inc. (the “Company,” “we,” “us” or “our”) was notified by the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s common stock was less than $1.00 over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the Company’scommon stock from the NYSE. On March 20, 2023 , the Company

View on SEC.gov

50 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

D-Wave Quantum Inc. filing history →

Source: SEC EDGAR

accession 0001140361-23-012814

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.